-
1
-
-
0038337815
-
The calpain system
-
Goll, D. E.; Thompson, V. F.; Li, H.; Wei, W. E. I.; Cong, J. The calpain system Phys. Rev. 2003, 83, 731-801
-
(2003)
Phys. Rev.
, vol.83
, pp. 731-801
-
-
Goll, D.E.1
Thompson, V.F.2
Li, H.3
Wei, W.E.I.4
Cong, J.5
-
2
-
-
0023866466
-
The ultrastructural localization of calcium-activated protease "calpain" in rat brain
-
Perlmutter, L. S.; Siman, R.; Gall, C.; Seubert, P.; Baudry, M.; Lynch, G. The ultrastructural localization of calcium-activated protease "calpain" in rat brain Synapse 1988, 2, 79-88
-
(1988)
Synapse
, vol.2
, pp. 79-88
-
-
Perlmutter, L.S.1
Siman, R.2
Gall, C.3
Seubert, P.4
Baudry, M.5
Lynch, G.6
-
3
-
-
4344566337
-
Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: Relevance to Alzheimer's disease
-
Veeranna; Kaji, T.; Boland, B.; Odrljin, T.; Mohan, P.; Basavarajappa, B. S.; Peterhoff, C.; Cataldo, A.; Rudnicki, A.; Amin, N.; Li, B. S.; Pant, H. C.; Hungund, B. L.; Arancio, O.; Nixon, R. A. Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease Am. J. Pathol. 2004, 165, 795-805
-
(2004)
Am. J. Pathol.
, vol.165
, pp. 795-805
-
-
Veeranna1
Kaji, T.2
Boland, B.3
Odrljin, T.4
Mohan, P.5
Basavarajappa, B.S.6
Peterhoff, C.7
Cataldo, A.8
Rudnicki, A.9
Amin, N.10
Li, B.S.11
Pant, H.C.12
Hungund, B.L.13
Arancio, O.14
Nixon, R.A.15
-
4
-
-
0030612795
-
Restriction of microM-calcium-requiring calpain activation to the plasma membrane in human neuroblastoma cells: Evidence for regionalized influence of a calpain activator protein
-
Shea, T. B. Restriction of microM-calcium-requiring calpain activation to the plasma membrane in human neuroblastoma cells: evidence for regionalized influence of a calpain activator protein J. Neurosci. Res. 1997, 48, 543-550
-
(1997)
J. Neurosci. Res.
, vol.48
, pp. 543-550
-
-
Shea, T.B.1
-
5
-
-
0036672695
-
Calpain inhibitors: A treatment for Alzheimer's disease
-
Di Rosa, G.; Odrijin, T.; Nixon, R. A.; Arancio, O. Calpain inhibitors: a treatment for Alzheimer's disease J. Mol. Neurosci. 2002, 19, 135-141
-
(2002)
J. Mol. Neurosci.
, vol.19
, pp. 135-141
-
-
Di Rosa, G.1
Odrijin, T.2
Nixon, R.A.3
Arancio, O.4
-
6
-
-
0034903587
-
The calpain family and human disease
-
Huang, Y.; Wang, K. K. W. The calpain family and human disease Trends Mol. Med. 2001, 7, 355-362
-
(2001)
Trends Mol. Med.
, vol.7
, pp. 355-362
-
-
Huang, Y.1
Wang, K.K.W.2
-
7
-
-
72949093813
-
Calpain as a therapeutic target in traumatic brain injury
-
Saatman, K.; Creed, J.; Raghupathi, R. Calpain as a therapeutic target in traumatic brain injury Neurotherapeutics 2010, 7, 31-42
-
(2010)
Neurotherapeutics
, vol.7
, pp. 31-42
-
-
Saatman, K.1
Creed, J.2
Raghupathi, R.3
-
8
-
-
0028098014
-
Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia
-
Hong, S. C.; Goto, Y.; Lanzino, G.; Soleau, S.; Kassell, N. F.; Lee, K. S. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia Stroke 1994, 25, 663-669
-
(1994)
Stroke
, vol.25
, pp. 663-669
-
-
Hong, S.C.1
Goto, Y.2
Lanzino, G.3
Soleau, S.4
Kassell, N.F.5
Lee, K.S.6
-
9
-
-
3342900223
-
2+-dependent proteases in ischemic neuronal death: A conserved "calpain-cathepsin cascade" from nematodes to primates
-
2+-dependent proteases in ischemic neuronal death: a conserved "calpain-cathepsin cascade" from nematodes to primates Cell Calcium 2004, 36, 285-293
-
(2004)
Cell Calcium
, vol.36
, pp. 285-293
-
-
Yamashima, T.1
-
10
-
-
0346102876
-
Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived αiI-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats
-
Pike, B. R.; Flint, J.; Dave, J. R.; Lu, X. C. M.; Wang, K. K. K.; Tortella, F. C.; Hayes, R. L. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived αII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats J. Cereb. Blood Flow Metab. 2004, 24, 98-106
-
(2004)
J. Cereb. Blood Flow Metab.
, vol.24
, pp. 98-106
-
-
Pike, B.R.1
Flint, J.2
Dave, J.R.3
Lu, X.C.M.4
Wang, K.K.K.5
Tortella, F.C.6
Hayes, R.L.7
-
11
-
-
84866167799
-
All cut up! the consequences of calpain activation on platelet function
-
Randriamboavonjy, V.; Fleming, I. All cut up! The consequences of calpain activation on platelet function Vasc. Pharmacol. 2012, 56, 210-215
-
(2012)
Vasc. Pharmacol.
, vol.56
, pp. 210-215
-
-
Randriamboavonjy, V.1
Fleming, I.2
-
12
-
-
84864066901
-
Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes
-
Randriamboavonjy, V.; Isaak, J.; Elgheznawy, A.; Pistrosch, F.; Fromel, T.; Yin, X.; Badenhoop, K.; Heide, H.; Mayr, M.; Fleming, I. Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes Blood 2012, 120, 415-423
-
(2012)
Blood
, vol.120
, pp. 415-423
-
-
Randriamboavonjy, V.1
Isaak, J.2
Elgheznawy, A.3
Pistrosch, F.4
Fromel, T.5
Yin, X.6
Badenhoop, K.7
Heide, H.8
Mayr, M.9
Fleming, I.10
-
13
-
-
0033613075
-
A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain
-
Shields, D. C.; Schaecher, K. E.; Saido, T. C.; Banik, N. L. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 11486-11491
-
(1999)
Proc. Natl. Acad. Sci. U.S.A.
, vol.96
, pp. 11486-11491
-
-
Shields, D.C.1
Schaecher, K.E.2
Saido, T.C.3
Banik, N.L.4
-
14
-
-
34250832784
-
Calpain-cleavage of α-synuclein: Connecting proteolytic processing to disease-linked aggregation
-
Dufty, B. M.; Warner, L. R.; Hou, S. T.; Jiang, S. X.; Gomez-Isla, T.; Leenhouts, K. M.; Oxford, J. T.; Feany, M. B.; Masliah, E.; Rohn, T. T. Calpain-cleavage of α-synuclein: connecting proteolytic processing to disease-linked aggregation Am. J. Pathol. 2007, 170, 1725-1738
-
(2007)
Am. J. Pathol.
, vol.170
, pp. 1725-1738
-
-
Dufty, B.M.1
Warner, L.R.2
Hou, S.T.3
Jiang, S.X.4
Gomez-Isla, T.5
Leenhouts, K.M.6
Oxford, J.T.7
Feany, M.B.8
Masliah, E.9
Rohn, T.T.10
-
15
-
-
53749096967
-
Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration
-
Vosler, P.; Brennan, C.; Chen, J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration Mol. Neurobiol. 2008, 38, 78-100
-
(2008)
Mol. Neurobiol.
, vol.38
, pp. 78-100
-
-
Vosler, P.1
Brennan, C.2
Chen, J.3
-
16
-
-
33644796419
-
Calpain may contribute to hereditary cataract formation in sheep
-
Robertson, L. J. G.; Morton, J. D.; Yamaguchi, M.; Bickerstaffe, R.; Shearer, T. R.; Azuma, M. Calpain may contribute to hereditary cataract formation in sheep Invest. Ophthalmol. Visual Sci. 2005, 46, 4634-4640
-
(2005)
Invest. Ophthalmol. Visual Sci.
, vol.46
, pp. 4634-4640
-
-
Robertson, L.J.G.1
Morton, J.D.2
Yamaguchi, M.3
Bickerstaffe, R.4
Shearer, T.R.5
Azuma, M.6
-
17
-
-
84888201515
-
Calpain-induced proteolysis in lens epithelial cell death during ovine inherited cataract
-
Robertson, L. J. G.; Nakajima, E.; Morton, J. D.; David, L. L.; Shearer, T. R.; Azuma, M. Calpain-induced proteolysis in lens epithelial cell death during ovine inherited cataract Invest. Ophthalmol. Visual Sci. 2004, 45, 2653
-
(2004)
Invest. Ophthalmol. Visual Sci.
, vol.45
, pp. 2653
-
-
Robertson, L.J.G.1
Nakajima, E.2
Morton, J.D.3
David, L.L.4
Shearer, T.R.5
Azuma, M.6
-
18
-
-
48249143207
-
Neuroprotection in glaucoma using calpain-1 inhibitors: Regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics
-
Govindarajan, B.; Laird, J.; Sherman, R.; Salomon, R. G.; Bhattacharya, S. K. Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics CNS Neurol. Disord: Drug Targets 2008, 7, 295-304
-
(2008)
CNS Neurol. Disord: Drug Targets
, vol.7
, pp. 295-304
-
-
Govindarajan, B.1
Laird, J.2
Sherman, R.3
Salomon, R.G.4
Bhattacharya, S.K.5
-
19
-
-
77949469511
-
Calpains: Attractive targets for the development of synthetic inhibitors
-
Pietsch, M.; Chua, K. C.; Abell, A. D. Calpains: attractive targets for the development of synthetic inhibitors Curr. Top. Med. Chem. 2010, 10, 270-293
-
(2010)
Curr. Top. Med. Chem.
, vol.10
, pp. 270-293
-
-
Pietsch, M.1
Chua, K.C.2
Abell, A.D.3
-
20
-
-
79955106083
-
Calpain inhibitors: A survey of compounds reported in the patent and scientific literature
-
Donkor, I. O. Calpain inhibitors: a survey of compounds reported in the patent and scientific literature Expert Opin. Ther. Pat. 2011, 21, 601-636
-
(2011)
Expert Opin. Ther. Pat.
, vol.21
, pp. 601-636
-
-
Donkor, I.O.1
-
21
-
-
0022182469
-
Calpain inhibition by peptide epoxides
-
Parkes, C.; Kembhavi, A. A.; Barrett, A. J. Calpain inhibition by peptide epoxides Biochem. J. 1985, 230, 509-516
-
(1985)
Biochem. J.
, vol.230
, pp. 509-516
-
-
Parkes, C.1
Kembhavi, A.A.2
Barrett, A.J.3
-
22
-
-
0018895711
-
Inhibition of epoxide derivatives on chicken calcium-activated neutral protease (CANP) in vitro and in vivo
-
Sugita, H.; Ishiura, S.; Suzuki, K.; Imahori, K. Inhibition of epoxide derivatives on chicken calcium-activated neutral protease (CANP) in vitro and in vivo Biochem. J. 1980, 87, 339-341
-
(1980)
Biochem. J.
, vol.87
, pp. 339-341
-
-
Sugita, H.1
Ishiura, S.2
Suzuki, K.3
Imahori, K.4
-
23
-
-
0017841848
-
Isolation and characterization of E-64, a new thiol protease inhibitor
-
K. Hanada, M. T.; Yamagishi, M.; Ohmura, S.; Sawada, J.; Tanaka, I. Isolation and characterization of E-64, a new thiol protease inhibitor Agric. Biol. Chem. 1978, 42, 523-528
-
(1978)
Agric. Biol. Chem.
, vol.42
, pp. 523-528
-
-
Hanada M T, K.1
Yamagishi, M.2
Ohmura, S.3
Sawada, J.4
Tanaka, I.5
-
24
-
-
0019948262
-
L - Trans -Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L
-
Barrett, A. J.; Kembhavi, A. A.; Brown, M. A.; Kirschke, H.; Knight, C. G.; Tamai, M.; Hanada, K. l-trans -Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L Biochem. J. 1982, 201, 189-198
-
(1982)
Biochem. J.
, vol.201
, pp. 189-198
-
-
Barrett, A.J.1
Kembhavi, A.A.2
Brown, M.A.3
Kirschke, H.4
Knight, C.G.5
Tamai, M.6
Hanada, K.7
-
25
-
-
48749089723
-
Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease
-
Trinchese, F.; Fa, M.; Liu, S.; Zhang, H.; Hidalgo, A.; Schmidt, S. D.; Yamaguchi, H.; Yoshii, N.; Mathews, P. M.; Nixon, R. A.; Arancio, O. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease J. Clin. Invest. 2008, 118, 2796-2807
-
(2008)
J. Clin. Invest.
, vol.118
, pp. 2796-2807
-
-
Trinchese, F.1
Fa, M.2
Liu, S.3
Zhang, H.4
Hidalgo, A.5
Schmidt, S.D.6
Yamaguchi, H.7
Yoshii, N.8
Mathews, P.M.9
Nixon, R.A.10
Arancio, O.11
-
26
-
-
0033835372
-
Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools
-
Greenbaum, D.; Medzihradszky, K. F.; Burlingame, A.; Bogyo, M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools Chem. Biol. 2000, 7, 569-581
-
(2000)
Chem. Biol.
, vol.7
, pp. 569-581
-
-
Greenbaum, D.1
Medzihradszky, K.F.2
Burlingame, A.3
Bogyo, M.4
-
27
-
-
0036775883
-
Small molecule affinity fingerprinting: A tool for enzyme family subclassification, target identification, and inhibitor design
-
Greenbaum, D. C.; Arnold, W. D.; Lu, F.; Hayrapetian, L.; Baruch, A.; Krumrine, J.; Toba, S.; Chehade, K.; Brömme, D.; Kuntz, I. D.; Bogyo, M. Small molecule affinity fingerprinting: a tool for enzyme family subclassification, target identification, and inhibitor design Chem. Biol. 2002, 9, 1085-1094
-
(2002)
Chem. Biol.
, vol.9
, pp. 1085-1094
-
-
Greenbaum, D.C.1
Arnold, W.D.2
Lu, F.3
Hayrapetian, L.4
Baruch, A.5
Krumrine, J.6
Toba, S.7
Chehade, K.8
Brömme, D.9
Kuntz, I.D.10
Bogyo, M.11
-
28
-
-
53049104836
-
Atomistic insights into the inhibition of cysteine proteases: First QM/MM calculations clarifying the stereoselectivity of epoxide-based inhibitors
-
Mladenovic, M.; Ansorg, K.; Fink, R. F.; Thiel, W.; Schirmeister, T.; Engels, B. Atomistic insights into the inhibition of cysteine proteases: first QM/MM calculations clarifying the stereoselectivity of epoxide-based inhibitors J. Phys. Chem. B 2008, 112, 11798-11808
-
(2008)
J. Phys. Chem. B
, vol.112
, pp. 11798-11808
-
-
Mladenovic, M.1
Ansorg, K.2
Fink, R.F.3
Thiel, W.4
Schirmeister, T.5
Engels, B.6
-
29
-
-
0343433408
-
Cysteine proteases and their inhibitors
-
Otto, H. H.; Schirmeister, T. Cysteine proteases and their inhibitors Chem. Rev. 1997, 97, 133-172
-
(1997)
Chem. Rev.
, vol.97
, pp. 133-172
-
-
Otto, H.H.1
Schirmeister, T.2
-
30
-
-
34248165038
-
Development of calpain-specific inactivators by screening of positional scanning epoxide libraries
-
Cuerrier, D.; Moldoveanu, T.; Campbell, R. L.; Kelly, J.; Yoruk, B.; Verhelst, S. H.; Greenbaum, D.; Bogyo, M.; Davies, P. L. Development of calpain-specific inactivators by screening of positional scanning epoxide libraries J. Biol. Chem. 2007, 282, 9600-9611
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 9600-9611
-
-
Cuerrier, D.1
Moldoveanu, T.2
Campbell, R.L.3
Kelly, J.4
Yoruk, B.5
Verhelst, S.H.6
Greenbaum, D.7
Bogyo, M.8
Davies, P.L.9
-
31
-
-
0033602268
-
New peptidic cysteine protease inhibitors derived from the electrophilic α-amino acid aziridine-2,3-dicarboxylic acid
-
Schirmeister, T. New peptidic cysteine protease inhibitors derived from the electrophilic α-amino acid aziridine-2,3-dicarboxylic acid J. Med. Chem. 1999, 42, 560-572
-
(1999)
J. Med. Chem.
, vol.42
, pp. 560-572
-
-
Schirmeister, T.1
-
32
-
-
84996318789
-
Phase i study of EST, a new thiol protease inhibitor - The 2nd report safety and pharmacokinetics in continuous administration
-
Miyahara, T.; Shimojo, S.; Toyohara, K.; Imai, T.; Miyajima, M.; Honda, H.; Kamegai, M.; Ohzeki, M.; Kokatsu, J.. Phase I study of EST, a new thiol protease inhibitor-the 2nd report safety and pharmacokinetics in continuous administration Rinsho Yakuri 1985, 16, 537-546
-
(1985)
Rinsho Yakuri
, vol.16
, pp. 537-546
-
-
Miyahara, T.1
Shimojo, S.2
Toyohara, K.3
Imai, T.4
Miyajima, M.5
Honda, H.6
Kamegai, M.7
Ohzeki, M.8
Kokatsu, J.9
-
33
-
-
0026656202
-
Therapeutic trials on progressive muscular dystrophy
-
Satoyashi, E. Therapeutic trials on progressive muscular dystrophy Intern. Med. 1992, 31, 841-846
-
(1992)
Intern. Med.
, vol.31
, pp. 841-846
-
-
Satoyashi, E.1
-
34
-
-
84888198277
-
-
Scrip 1992, 1765.
-
(1992)
Scrip
, pp. 1765
-
-
-
35
-
-
0022997931
-
In vitro and in vivo inhibition of cysteine proteases by EST, a new analog of E-64
-
M. Tamai, K. M.; Omura, S.; Koyama, I.; Ozawa, Y.; Hanada, K. In vitro and in vivo inhibition of cysteine proteases by EST, a new analog of E-64 J. Pharmacobio-Dyn. 1986, 9, 672-677
-
(1986)
J. Pharmacobio-Dyn.
, vol.9
, pp. 672-677
-
-
Tamai K M, M.1
Omura, S.2
Koyama, I.3
Ozawa, Y.4
Hanada, K.5
-
36
-
-
0026029556
-
Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo
-
Towatari, T.; Nikawa, T.; Murata, M.; Yokoo, C.; Tamai, M.; Hanada, K.; Katunuma, N. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo FEBS Lett. 1991, 280, 311-315
-
(1991)
FEBS Lett.
, vol.280
, pp. 311-315
-
-
Towatari, T.1
Nikawa, T.2
Murata, M.3
Yokoo, C.4
Tamai, M.5
Hanada, K.6
Katunuma, N.7
-
37
-
-
34547901415
-
Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics
-
Hook, G.; Hook, V. Y.; Kindy, M. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics Biol. Chem. 2007, 388, 979-983
-
(2007)
Biol. Chem.
, vol.388
, pp. 979-983
-
-
Hook, G.1
Hook, V.Y.2
Kindy, M.3
-
38
-
-
0023607871
-
Prolongation of life span of dystrophic hamster by cysteine proteinase inhibitor, loxistatin (EST)
-
Tamai, M.; Omura, S.; Kimura, M.; Hanada, K.; Sugita, H. Prolongation of life span of dystrophic hamster by cysteine proteinase inhibitor, loxistatin (EST) J. Pharmacobio-Dyn. 1987, 10, 678-681
-
(1987)
J. Pharmacobio-Dyn.
, vol.10
, pp. 678-681
-
-
Tamai, M.1
Omura, S.2
Kimura, M.3
Hanada, K.4
Sugita, H.5
-
39
-
-
0000180596
-
Reactions of α β-epoxy carbonyl compounds with methanethiolate: Regioselectivity and rate
-
Bihovsky, R. Reactions of.alpha.,.beta.-epoxy carbonyl compounds with methanethiolate: regioselectivity and rate J. Org. Chem. 1992, 57, 1029-1031
-
(1992)
J. Org. Chem.
, vol.57
, pp. 1029-1031
-
-
Bihovsky, R.1
-
40
-
-
85026877529
-
Dietyhl (2 S,2 R)-2(N - Tert -butoxycarbonyl)amino-3-hydroxysuccinate
-
Saito, S.; Komada, K.; Moriwake, T.. Dietyhl (2 S,2 R)-2(N-tert -butoxycarbonyl)amino-3-hydroxysuccinate Org. Synth. 1996, 73, 184
-
(1996)
Org. Synth.
, vol.73
, pp. 184
-
-
Saito, S.1
Komada, K.2
Moriwake, T.3
-
41
-
-
0037040423
-
2+ switch aligns the active site of calpain
-
2+ switch aligns the active site of calpain Cell 2002, 108, 649-660
-
(2002)
Cell
, vol.108
, pp. 649-660
-
-
Moldoveanu, T.1
Hosfield, C.M.2
Lim, D.3
Elce, J.S.4
Jia, Z.5
Davies, P.L.6
-
42
-
-
6344285318
-
Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site
-
Moldoveanu, T.; Campbell, R. L.; Cuerrier, D.; Davies, P. L. Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site J. Mol. Biol. 2004, 343, 1313-1326
-
(2004)
J. Mol. Biol.
, vol.343
, pp. 1313-1326
-
-
Moldoveanu, T.1
Campbell, R.L.2
Cuerrier, D.3
Davies, P.L.4
-
43
-
-
33745165901
-
Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography
-
Cuerrier, D.; Moldoveanu, T.; Inoue, J.; Davies, P. L.; Campbell, R. L. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography Biochemistry 2006, 45, 7446-7452
-
(2006)
Biochemistry
, vol.45
, pp. 7446-7452
-
-
Cuerrier, D.1
Moldoveanu, T.2
Inoue, J.3
Davies, P.L.4
Campbell, R.L.5
-
44
-
-
28844491633
-
Determination of peptide substrate specificity for μ-calpain by a peptide library-based approach
-
Cuerrier, D.; Moldoveanu, T.; Davies, P. L. Determination of peptide substrate specificity for μ-calpain by a peptide library-based approach J. Biol. Chem. 2005, 280, 40632-40641
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 40632-40641
-
-
Cuerrier, D.1
Moldoveanu, T.2
Davies, P.L.3
-
45
-
-
0021096579
-
Amino acid sequence around the active site cysteine residue of calcium-activated neutral protease (CANP)
-
Suzuki, K.; Hayashi, H.; Hayashi, T.; Iwai, K. Amino acid sequence around the active site cysteine residue of calcium-activated neutral protease (CANP) FEBS Lett. 1983, 152, 67-70
-
(1983)
FEBS Lett.
, vol.152
, pp. 67-70
-
-
Suzuki, K.1
Hayashi, H.2
Hayashi, T.3
Iwai, K.4
-
46
-
-
79955053789
-
An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals
-
Baumann, M.; Baxendale, I. R.; Ley, S. V.; Nikbin, N. An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals Beilstein J. Org. Chem. 2011, 7, 442-495
-
(2011)
Beilstein J. Org. Chem.
, vol.7
, pp. 442-495
-
-
Baumann, M.1
Baxendale, I.R.2
Ley, S.V.3
Nikbin, N.4
-
47
-
-
84872324395
-
Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: Caspase-9 inhibition provides therapeutic protection
-
Tamayev, R.; Akpan, N.; Arancio, O.; Troy, C. M.; L, D. A. Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: caspase-9 inhibition provides therapeutic protection Mol. Neurodegener. 2012, 7, 60
-
(2012)
Mol. Neurodegener.
, vol.7
, pp. 60
-
-
Tamayev, R.1
Akpan, N.2
Arancio, O.3
Troy, C.M.4
-
48
-
-
78650659370
-
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
-
D'Amelio, M.; Cavallucci, V.; Middei, S.; Marchetti, C.; Pacioni, S.; Ferri, A.; Diamantini, A.; De Zio, D.; Carrara, P.; Battistini, L.; Moreno, S.; Bacci, A.; Ammassari-Teule, M.; Marie, H.; Cecconi, F. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease Nat. Neurosci. 2011, 14, 69-76
-
(2011)
Nat. Neurosci.
, vol.14
, pp. 69-76
-
-
D'Amelio, M.1
Cavallucci, V.2
Middei, S.3
Marchetti, C.4
Pacioni, S.5
Ferri, A.6
Diamantini, A.7
De Zio, D.8
Carrara, P.9
Battistini, L.10
Moreno, S.11
Bacci, A.12
Ammassari-Teule, M.13
Marie, H.14
Cecconi, F.15
-
49
-
-
43149100823
-
Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein
-
Hook, V. Y.; Kindy, M.; Hook, G. Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein J. Biol. Chem. 2008, 283, 7745-7753
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 7745-7753
-
-
Hook, V.Y.1
Kindy, M.2
Hook, G.3
-
50
-
-
80052821752
-
The cysteine protease inhibitor, E64d, reduces brain amyloid-beta and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, beta-secretase activity
-
Hook, G.; Hook, V.; Kindy, M. The cysteine protease inhibitor, E64d, reduces brain amyloid-beta and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, beta-secretase activity J. Alzheimer's Dis. 2011, 26, 387-408
-
(2011)
J. Alzheimer's Dis.
, vol.26
, pp. 387-408
-
-
Hook, G.1
Hook, V.2
Kindy, M.3
-
51
-
-
84873964654
-
Cathepsin B degrades amyloid-beta in mice expressing wild-type human amyloid precursor protein
-
Wang, C.; Sun, B.; Zhou, Y.; Grubb, A.; Gan, L. Cathepsin B degrades amyloid-beta in mice expressing wild-type human amyloid precursor protein J. Biol. Chem. 2012, 287, 39834-39841
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 39834-39841
-
-
Wang, C.1
Sun, B.2
Zhou, Y.3
Grubb, A.4
Gan, L.5
-
52
-
-
0037187412
-
Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: Insight into structure-based ligand design
-
Huo, S.; Wang, J.; Cieplak, P.; Kollman, P. A.; Kuntz, I. D. Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: insight into structure-based ligand design J. Med. Chem. 2002, 45, 1412-1419
-
(2002)
J. Med. Chem.
, vol.45
, pp. 1412-1419
-
-
Huo, S.1
Wang, J.2
Cieplak, P.3
Kollman, P.A.4
Kuntz, I.D.5
-
53
-
-
80052949153
-
Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: The utility of incorporating protein flexibility via an ensemble of structures
-
Danielson, M. L.; Desai, P. V.; Mohutsky, M. A.; Wrighton, S. A.; Lill, M. A. Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: the utility of incorporating protein flexibility via an ensemble of structures Eur. J. Med. Chem. 2011, 46, 3953-3963
-
(2011)
Eur. J. Med. Chem.
, vol.46
, pp. 3953-3963
-
-
Danielson, M.L.1
Desai, P.V.2
Mohutsky, M.A.3
Wrighton, S.A.4
Lill, M.A.5
-
54
-
-
73449135498
-
Fast prediction of cytochrome P450 mediated drug metabolism
-
Rydberg, P.; Vasanthanathan, P.; Oostenbrink, C.; Olsen, L. Fast prediction of cytochrome P450 mediated drug metabolism ChemMedChem 2009, 4, 2070-2079
-
(2009)
ChemMedChem
, vol.4
, pp. 2070-2079
-
-
Rydberg, P.1
Vasanthanathan, P.2
Oostenbrink, C.3
Olsen, L.4
-
55
-
-
80052380142
-
Structure-based site of metabolism prediction for cytochrome P450 2D6
-
Moors, S. L.; Vos, A. M.; Cummings, M. D.; Van Vlijmen, H.; Ceulemans, A. Structure-based site of metabolism prediction for cytochrome P450 2D6 J. Med. Chem. 2011, 54, 6098-6105
-
(2011)
J. Med. Chem.
, vol.54
, pp. 6098-6105
-
-
Moors, S.L.1
Vos, A.M.2
Cummings, M.D.3
Van Vlijmen, H.4
Ceulemans, A.5
-
56
-
-
57149136433
-
The Protein Data Bank (PDB), its related services and software tools as key components for in silico guided drug discovery
-
Kirchmair, J.; Markt, P.; Distinto, S.; Schuster, D.; Spitzer, G. M.; Liedl, K. R.; Langer, T.; Wolber, G. The Protein Data Bank (PDB), its related services and software tools as key components for in silico guided drug discovery J. Med. Chem. 2008, 51, 7021-7040
-
(2008)
J. Med. Chem.
, vol.51
, pp. 7021-7040
-
-
Kirchmair, J.1
Markt, P.2
Distinto, S.3
Schuster, D.4
Spitzer, G.M.5
Liedl, K.R.6
Langer, T.7
Wolber, G.8
-
57
-
-
4444221565
-
UCSF Chimera - A visualization system for exploratory research and analysis
-
Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera-a visualization system for exploratory research and analysis J. Comput. Chem. 2004, 25, 1605-1612
-
(2004)
J. Comput. Chem.
, vol.25
, pp. 1605-1612
-
-
Pettersen, E.F.1
Goddard, T.D.2
Huang, C.C.3
Couch, G.S.4
Greenblatt, D.M.5
Meng, E.C.6
Ferrin, T.E.7
-
58
-
-
84881398795
-
-
Molecular Operating Environment.
-
Molecular Operating Environment. http://www.chemcomp.com.
-
-
-
-
59
-
-
0028854034
-
Molecular recognition of receptor-sites using a genetic algorithm with a description of desolvation
-
Jones, G.; Willett, P.; Glen, R. C. Molecular recognition of receptor-sites using a genetic algorithm with a description of desolvation J. Mol. Biol. 1995, 245, 43-53
-
(1995)
J. Mol. Biol.
, vol.245
, pp. 43-53
-
-
Jones, G.1
Willett, P.2
Glen, R.C.3
|